Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IDXX
IDXX logo

IDXX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy IDEXX Laboratories Inc (IDXX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
600.520
1 Day change
0.28%
52 Week Range
769.980
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IDXX is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown solid financial growth in its latest quarter, the mixed analyst sentiment, lack of recent positive news catalysts, and neutral technical indicators suggest waiting for a clearer entry point or stronger signals.

Technical Analysis

The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral at 33.851, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its support level (S1: 621.065) but below the pivot level (640.887), indicating limited upward momentum in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
5

Positive Catalysts

  • Hedge funds are significantly increasing their positions in IDXX, with a 764.05% increase in buying activity over the last quarter. The company also delivered strong financial growth in Q4 2025, with revenue, net income, and EPS all showing double-digit YoY growth.

Neutral/Negative Catalysts

  • Analysts have lowered price targets recently, citing concerns about muted Q1 growth, softer gross margin outlook for 2026, and slower inVue placements. No recent news or congress trading data is available to provide additional positive sentiment.

Financial Performance

In Q4 2025, revenue increased by 14.28% YoY to $1.09 billion, net income rose by 14.82% YoY to $248.19 million, and EPS grew by 17.56% YoY to 3.08. Gross margin improved slightly to 60.35%, up 0.92% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. Piper Sandler, UBS, and Barclays lowered their price targets recently, citing concerns about muted growth and macro headwinds. However, Barclays and BTIG maintain an Overweight/Buy rating, reflecting long-term optimism despite near-term challenges.

Wall Street analysts forecast IDXX stock price to rise
10 Analyst Rating
Wall Street analysts forecast IDXX stock price to rise
7 Buy
3 Hold
0 Sell
Moderate Buy
Current: 598.850
sliders
Low
750
Averages
792.78
High
850
Current: 598.850
sliders
Low
750
Averages
792.78
High
850
Piper Sandler
Neutral
downgrade
$775 -> $750
AI Analysis
2026-02-09
Reason
Piper Sandler
Price Target
$775 -> $750
AI Analysis
2026-02-09
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Idexx Laboratories to $750 from $775 and keeps a Neutral rating on the shares following quarterly results. The firm says its updated price target primarily reflects its updated multiple and rolling forward of estimates to 2027 from 2026.
Barclays
Glen Santangelo
Overweight
downgrade
$850 -> $800
2026-02-05
Reason
Barclays
Glen Santangelo
Price Target
$850 -> $800
2026-02-05
downgrade
Overweight
Reason
Barclays analyst Glen Santangelo lowered the firm's price target on Idexx Laboratories to $800 from $850 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q4 repot, saying the fiscal 2026outlook "underwhelmed."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IDXX
Unlock Now

People Also Watch